Myopia in Children: Atropine Eyedrops Study

We are testing two concentrations of atropine eyedrops to see if they can slow the progression of myopia in children and teens aged 3 to under 18. The study will also look at safety and how vision affects daily life.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Atropine
Atropine is a substance that increases heart rate, reduces bodily secretions, and dilates pupils for examinations or emergencies.
Atropine Sulfate Monohydrate
Atropine sulfate monohydrate is a substance that blocks certain nerve signals to increase heart rate, reduce secretions, and dilate pupils.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Atropine

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
University Of Bari Aldo Moro
Istituto di Oftalmologia
Altamura, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
SSD Oftalmologia
Milan, Italy
Azienda Ospedaliera di Padova
UOC Clinica oculistica
Padova, Italy

Sponsor: Ocus Innovation Ireland Limited
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.